Dereja in partnership with the Ministry of Labor and Skills (MOLS) and the Mastercard Foundation is hosting a series of career expos in five public universities to connect recent graduates with employers across the country. The expos are being hosted at Addis Ababa, Haromaya, Hawassa, Jimma, and Bahir Dar Universities between June and August 2022. They serve as an offline employment linkage platform that helps graduating students secure jobs before their graduation.
The first set of expos held in June brought together a total of 2,000 students and 80 employers, including Heineken Breweries share company, Enat Bank, Huawei International, Save the Children International, People in Need, World Vision Ethiopia, and Unilever Manufacturing PLC.
Last week an annual career expo was held at the Addis Ababa University Sedist Kilo Campus. Over 70 national and international companies were represented at the event, including the National Electoral Board of Ethiopia (NEBE), The United Nations Office for Project Services (UNOPS). Habitat for Humanity, Ahadu pic, Horra Trading, Care Ethiopia, Commercial Bank of Ethiopia, Micro Pharma pic, and EthioChicken. More than1,500 graduates attended.
Dereja hosts career expos for over 4,000 new graduates
AfDB Board approves establishment of African Pharmaceutical Technology Foundation
The African Development Bank’s Board of Directors has approved the establishment of the African Pharmaceutical Technology Foundation, a new groundbreaking institution that will significantly enhance Africa’s access to the technologies that underpin the manufacture of medicines, vaccines, and other pharmaceutical products.
African Development Bank Group President, Dr. Akinwumi Adesina said: “This is a great development for Africa. Africa must have a health defense system, which must include three major areas: revamping Africa’s pharmaceutical industry, building Africa’s vaccine manufacturing capacity, and building Africa’s quality healthcare infrastructure.”
During the African Union Summit in Addis Ababa in February 2022, the continent’s leaders called on the African Development Bank to facilitate the establishment of the African Pharmaceutical Technology Foundation. Adesina, who presented the case for the institution to the African Union said: “Africa can no longer outsource the healthcare security of its 1.3 billion citizens to the benevolence of others.” With this bold initiative, the African Development Bank has made good on that commitment.
Novartis announces $250 million to the fight against NTDs
Novartis endorses the Kigali Declaration on neglected tropical diseases (NTDs) and announces a five-year financial commitment of USD 250 million to the fight against NTDs and malaria in conjunction with the Kigali Summit on Malaria and
NTDs alongside the 26th Commonwealth Heads of Government (CHOGM) meeting. This summit comes at a pivotal time for world leaders to reaffirm commitments to end neglected tropical diseases and malaria through the adoption of the Kigali Declaration. The declaration aims to mobilize political will and secure commitments to achieve the SDG3 target on NTDs and to deliver the targets set out in the World Health Organization’s Neglected Tropical Disease Roadmap (2021-2030).
“Over the past decade, great progress has been made against NTDs, but there is still a lot more work to be done. Novartis will continue progressing our longstanding commitment to helping realize a world free of NTDs,” said Vas Narasimhan, CEO of Novartis.
50,000 wild species meet needs of billions worldwide
Billions of people, in developed and developing nations, benefit daily from the use of wild species for food, energy, materials, medicine, recreation, inspiration and many other vital contributions to human well-being. The accelerating global biodiversity crisis, with a million species of plants and animals facing extinction, threatens these contributions to people. A new report by the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES) offers insights, analysis and tools to establish more sustainable use of wild species of plants, animals, fungi and algae around the world. Sustainable use is when biodiversity and ecosystem functioning are maintained while contributing to human well-being.
The IPBES Assessment Report on the Sustainable Use of Wild Species is the result of four years of work by 85 leading experts from the natural and social sciences, and holders of indigenous and local knowledge, as well as 200 contributing authors, drawing on more than 6,200 sources. The summary of the Report was approved this week by representatives of the 139 member States of IPBES in Bonn, Germany.
